- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer Center
Wednesday, November 2, 2005
OncoLink's daily online reports from the Chemotherapy Foundation Symposium in New York City on November 2-5, 2005. |
|
Adjuvant Therapy for Rectal Cancer
Presenter: Bruce D. Minsky, MDPresenter's Affiliation: Memorial Sloan Kettering Cancer Center, New York, New YorkType of Session: ScientificBackground Based on data published in the Journal of Clinical Oncology, it has become apparent that... |
|
|
Approaches to Imatinib-resistant GIST
Gastrointestinal stromal tumors (GIST) are the most common sarcomas, with about 3000 - 3,500 cases reported each year. The standard of care for locaized GIST is surgical resection. Unfortunately, the recurrence rate can be as high as 60-80% in some... |
|
|
Bevacizumab (Avastin) Plus Oxaliplatin-Based Combination Chemotherapy:Update on Recent Trials
Presenter: Howard S. Hochster, MD.Presenter's Affiliation: New York University Cancer Institute, New York, New YorkType of Session: ScientificBackground 5-Fluorouracil (5FU) is a very old chemotherapy drug for colorectal cancer, and recent... |
|
|
Gemcitabine and Erlotinib in Pancreatic Cancer
Presenter: Malcolm Moore, MDPresenter's Affiliation: Princess Margaret HospitalType of Session: ScientificBackground Pancreatic cancer is the fourth leading cause of cancer-related deaths. In 2005, there will be an estimated 35,400 new... |
|
|
PTK787: A Small Molecule Inhibitor of VEGF-Receptors
Presenter: J. Randolph Hecht, MDPresenter's Affiliation: UCLA GI Oncology Program, Los Angeles, CaliforniaType of Session: ScientificBackground Growing tumors need access to nutrients and a blood supply, and the process of new blood vessel... |
|
|
The Role of Chemotherapy and Biologic Therapy in the Treatment of Metastatic Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer diagnosed in men and women in the US, with an estimated annual incidence of almost 150,000 new cases. In terms of cancer-related deaths in the US, it ranks second (after lung cancer), with about... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
